Nuclera

Nuclera is a Cambridge-based biotechnology company developing benchtop systems for rapid protein expression and screening.

Its discovery platform integrates cell-free protein synthesis, digital microfluidics, and automated construct screening to deliver soluble, active proteins in under 48 hours.

The system is designed to accelerate protein-dependent workflows in drug discovery, biologics development, and research, reducing the time and cost traditionally associated with protein expression and purification.